Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 40: 562-564, 1994;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haddow, J. E.
Right arrow Articles by Chilmonczyk, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haddow, J. E.
Right arrow Articles by Chilmonczyk, B. A.

Clinical Chemistry, Vol 40, 562-564, Copyright © 1994 by American Association for Clinical Chemistry

Replacing creatinine measurements with specific gravity values to adjust urine cotinine concentrations

JE Haddow, GJ Knight, GE Palomaki, LM Neveux and BA Chilmonczyk
Foundation for Blood Research, Scarborough, ME 04070-0190.

Creatinine and specific gravity (relative density) measurements both allow differences in urine concentration to be taken into account in determining urine cotinine concentrations. In this study we demonstrate that the variance of urine cotinine measurements is reduced comparably when either creatinine or specific gravity measurements are used for correction. This reduction in variability improves the correlation between urine cotinine measurements and clinical endpoints. In this study, the clinical endpoints were pulmonary function in a population of nonsmoking children with asthma, 42% of whom were reported to have been exposed to environmental tobacco smoke. When corrected by either creatinine measurements or specific gravity values, the urine cotinine measurements performed as well or better than reported exposure (and comparably with each other) in assessments of lung function. A dose- response relationship was also more consistently apparent. Specific gravity values can be used reliably in place of creatinine values to adjust urine cotinine measurements for both research and clinical purposes.


The following articles in journals at HighWire Press have cited this article:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. A. McElroy, M. M. Shafer, R. E. Gangnon, L. A. Crouch, and P. A. Newcomb
Urinary Lead Exposure and Breast Cancer Risk in a Population-Based Case-Control Study
Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2311 - 2317.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. C. Miller, E. Brindle, D. J. Holman, J. Shofer, N. A. Klein, M. R. Soules, and K. A. O'Connor
Comparison of Specific Gravity and Creatinine for Normalizing Urinary Reproductive Hormone Concentrations
Clin. Chem., May 1, 2004; 50(5): 924 - 932.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. Jatlow, S. McKee, and S. S. O'Malley
Correction of Urine Cotinine Concentrations for Creatinine Excretion: Is It Useful?
Clin. Chem., November 1, 2003; 49(11): 1932 - 1934.
[Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
E Kohler, D Bretschneider, A Rabsilber, W Weise, and G Jorch
Assessment of prenatal smoke exposure by determining nicotine and its metabolites in maternal and neonatal urine
Human and Experimental Toxicology, January 1, 2001; 20(1): 1 - 7.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Association for Clinical Chemistry.